6 research outputs found
Postcombustion CO<sub>2</sub> Capture in Functionalized Porous Coordination Networks
Motivated
by recent experimental reports of zirconium porous coordination
networks (PCNs) [<i>J. Am. Chem. Soc.</i> <b>2012</b>, <i>134</i>, 14690–14693], which have demonstrated
a good stability and CO<sub>2</sub> adsorption capacity, we investigate
the influence of flue gas impurities and functional groups on the
performance of PCN frameworks in selective CO<sub>2</sub> capture.
Using a combination of grand canonical Monte Carlo (GCMC) simulations
and first-principles calculations, we find that O<sub>2</sub> and
SO<sub>2</sub> impurities in flue gas have a negligible influence
on CO<sub>2</sub> selectivity in all PCN frameworks. However, because
of strong electrostatic interaction between H<sub>2</sub>O molecules
and the framework, CO<sub>2</sub> selectivity decreases in all PCN
structures in the presence of water impurities in the flue gas. Our
studies suggest that the PCN-59 framework can be a good candidate
for selective CO<sub>2</sub> separation from a predehydrated flue
gas mixture
Discovery of the First <i>N</i>‑Hydroxycinnamamide-Based Histone Deacetylase 1/3 Dual Inhibitors with Potent Oral Antitumor Activity
In our previous study, we designed
and synthesized a novel series
of <i>N</i>-hydroxycinnamamide-based HDAC inhibitors (HDACIs),
among which the representative compound <b>14a</b> exhibited
promising HDACs inhibition and antitumor activity. In this current
study, we report the development of a more potent class of <i>N</i>-hydroxycinnamamide-based HDACIs, using <b>14a</b> as lead, among which, compound <b>11r</b> gave IC<sub>50</sub> values of 11.8, 498.1, 3.9, 2000.8, 5700.4, 308.2, and 900.4 nM
for the inhibition of HDAC1, HDAC2, HDAC3, HDAC8, HDAC4, HDAC6, and
HDAC11, exhibiting dual HDAC1/3 selectivity. Compounds <b>11e</b>, <b>11r</b>, <b>11w</b>, and <b>11y</b> showed
excellent growth inhibition in multiple tumor cell lines. In vivo
antitumor assay in U937 xenograft model identified compound <b>11r</b> as a potent, orally active HDACI. To the best of our knowledge,
this work constitutes the first report of oral active <i>N</i>-hydroxycinnamamide-based HDACIs with dual HDAC1/3 selectivity
Multiscale Structural Engineering Boosts Piezoelectricity in Na<sub>0.5</sub>Bi<sub>2.5</sub>Nb<sub>2</sub>O<sub>9</sub>‑Based High-Temperature Piezoceramics
High-temperature
piezoelectric materials, which enable the accurate
and reliable sensing of physical parameters to guarantee the functional
operation of various systems under harsh conditions, are highly demanded.
To this end, both large piezoelectricity and high Curie temperature
are pivotal figures of merit (FOMs) for high-temperature piezoceramics.
Unfortunately, despite intensive pursuits, it remains a formidable
challenge to unravel the inverse correlation between these FOMs. Herein,
a conceptual material paradigm of multiscale structural engineering
was proposed to address this dilemma. The synergistic effects of phase
structure reminiscent of a polymorphic phase boundary and refined
domain morphology simultaneously contribute to a large piezoelectric
coefficient d33 of 30.3 pC/N and a high
Curie temperature TC of 740 °C in
(LiCeNd) codoped Na0.5Bi2.5Nb2O9 (NBN-LCN) ceramics. More encouragingly, the system has exceptional
thermal stability and is nonsusceptible to mechanical loading. This
study not only demonstrates that the high-performance and robust NBN-LCN
high-temperature piezoceramics hold great potential for implements
under harsh conditions but also opens an avenue for integrating antagonistic
properties for the enhancement of the collective performance in functional
materials
Insights into the Impact of a Membrane-Anchoring Moiety on the Biological Activities of Bivalent Compounds As Potential Neuroprotectants for Alzheimer’s Disease
Bivalent
compounds anchoring in different manners to the membrane
were designed and biologically characterized to understand the contribution
of the anchor moiety to their biological activity as neuroprotectants
for Alzheimer’s disease. Our results established that the anchor
moiety is essential, and we identified a preference for diosgenin,
as evidenced by <b>17MD</b>. Studies in primary neurons and
mouse brain mitochondria also identified <b>17MD</b> as exhibiting
activity on neuritic outgrowth and the state 3 oxidative rate of glutamate
while preserving the coupling capacity of the mitochondria. Significantly,
our studies demonstrated that the integrated bivalent structure is
essential to the observed biological activities. Further studies employing
bivalent compounds as probes in a model membrane also revealed the
influence of the anchor moiety on how they interact with the membrane.
Collectively, our results suggest diosgenin to be an optimal anchor
moiety, providing bivalent compounds with promising pharmacology that
have potential applications for Alzheimer’s disease
Structural Insights of Benzenesulfonamide Analogues as NLRP3 Inflammasome Inhibitors: Design, Synthesis, and Biological Characterization
NLRP3 inflammasome plays critical
roles in a variety of human diseases
and represents a promising drug target. In this study, we established
the in vivo functional activities of <b>JC124</b>, a previously
identified NLRP3 inflammasome inhibitor from our group, in mouse models
of Alzheimer’s disease and acute myocardial infarction. To
understand the chemical space of this lead structure, a series of
analogues were designed, synthesized, and biologically characterized.
The results revealed the critical roles of the two substituents on
the benzamide moiety of <b>JC124</b>. On the other hand, modifications
on the sulfonamide moiety of <b>JC124</b> are well tolerated.
Two new lead compounds, <b>14</b> and <b>17</b>, were
identified with improved inhibitory potency (IC<sub>50</sub> values
of 0.55 ± 0.091 and 0.42 ± 0.080 μM, respectively).
Further characterization confirmed their selectivity and in vivo target
engagement. Collectively, the results strongly encourage further development
of more potent analogues based on this chemical scaffold
Data_Sheet_1_Associations of phthalates with NAFLD and liver fibrosis: A nationally representative cross-sectional study from NHANES 2017 to 2018.docx
ObjectiveAlthough phthalates are common environmental pollutants, few studies have focused on the relationship of phthalates exposure with non-alcoholic fatty liver disease (NAFLD) or liver fibrosis, and especially, the alternative phthalates have been questioned in recent years about whether they are better choices. Thus, this study aimed to explore the associations of exposure to major phthalates or alternative phthalates with NAFLD and liver fibrosis.MethodsData of 1450 adults from the National Health and Nutrition Examination Survey (NHANES) 2017-2018 were collected. The urinary metabolite concentrations of di-2-ethylhexyl phthalate (DEHP), diisononyl phthalate (DINP) and diisodecyl phthalate (DIDP) were detected. Controlled attenuation parameter (CAP) and median liver stiffness measurement (LSM) were acquired for quantitative diagnosis of NAFLD and liver fibrosis by vibration-controlled transient elastography. Multivariate logistic regression analysis and linear regression analysis were performed to examine the associations between phthalates and NAFLD and liver fibrosis.ResultsAfter adjustment of the potential factors, the prevalence of NAFLD was significantly elevated among those in the fourth quartile of mono-(2-ethyl-5-carboxypentyl) phthalate (OR, 95%CI = 2.719, 1.296, 5.700, P = 0.016), mono (2-ethyl-5-hydroxyhexyl) phthalate (OR, 95%CI = 2.073, 1.111, 3.867, P = 0.037). No significant association was found between the alternative phthalates and NAFLD. The similar result was gained by linear regression analysis that MECPP was still significantly associated with Ln CAP (Q4 vs. Q1: β, 95%CI = 0.067, 0.017, 0.118, P = 0.027). After adjustment for the same covariates, no significant association between phthalates and liver fibrosis was found in logistics regression analysis.ConclusionsAll in all, higher prevalence of NAFLD is correlated with DEHP but not DINP or DIDP in American adults. There is no significant relationship between phthalates and liver fibrosis defined as LSM ≥ 8 Kpa. Nevertheless, further research is needed to provide evidence of causality.</p